Response to: ‘Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors’ by Jovaniet al
Open Access
- 10 June 2020
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 81 (7), e132
- https://doi.org/10.1136/annrheumdis-2020-218179
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 2Arthritis & Rheumatology, 2020
- Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New YorkThe New England Journal of Medicine, 2020
- Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitorsAnnals Of The Rheumatic Diseases, 2020
- SAT0409 BIOLOGIC TREATMENT IN PSORIATIC ARTHRITIS AND AXIAL SPONDYLOPATHY REDUCES SICKNOTES ISSUED BY GPS, DESPITE DELAYS IN DIAGNOSIS: A REAL-LIFE STUDY IN WALES.Annals Of The Rheumatic Diseases, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Clinical features of rheumatic patients infected with COVID-19 in Wuhan, ChinaAnnals Of The Rheumatic Diseases, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 1Arthritis & Rheumatology, 2020